Status:
RECRUITING
Cervical Cancer Detection Using Optical Spectroscopy
Lead Sponsor:
Duke University
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
Eligibility Criteria
Inclusion
- undergoing colposcopy for the diagnosis of cervical cancer
- LEEP for the treatment of cervical cancer in early stages.
- Follow-up Pap smear in surveillance
Exclusion
- Women under the age of 18 (minors) will be excluded from this study.
- patients will be excluded if she has had a recent episode of bleeding or preterm labor.
- Subjects who are not competent to give consent will excluded
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00900575
Start Date
May 1 2006
End Date
January 31 2026
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710